Roy Sirkis

Roy Sirkis is a highly experienced biotechnology professional currently serving as Chief Technology Officer at OmnigeniQ since March 2025. Prior roles include Co-Head and Site Manager of EmendoBio Israel at Emendo Biotherapeutics, where responsibilities spanned from VP of Bio-Materials Development and Production to Director of Protein Production from February 2020 to March 2025. Sirkis's career includes key positions such as Senior Researcher at IBI-AG, Antibody Project Lead at Fibron, and Biochemical System Improvement Lead at Monsanto (Beeologics). A former Project Manager at Procore LTD, Sirkis focused on technological platform development and process optimization. Academic qualifications include an MBA in Biomedical Sciences from The College of Management Academic Studies and a PhD in Structural Biology from the Weizmann Institute of Science.